<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03876093</url>
  </required_header>
  <id_info>
    <org_study_id>Epilepsy-related brain tumors</org_study_id>
    <nct_id>NCT03876093</nct_id>
  </id_info>
  <brief_title>Epilepsy-related Brain Tumors Register</brief_title>
  <official_title>Epilepsy-related Brain Tumors Register</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epilepsy is defined by a cerebral disorder characterized by a lasting predisposition to&#xD;
      generate epileptic seizures and by the neurobiological, cognitive, psychological and social&#xD;
      consequences of this affection. The definition of epilepsy requires the occurrence of at&#xD;
      least one epileptic seizure. 1% of the population suffers from epilepsy. The most common&#xD;
      causes are genetic and vascular, 10% of epileptic syndromes are caused by a tumor.&#xD;
&#xD;
      The incidence of brain tumors in people with epilepsy is approximately 4%. Among patients&#xD;
      with brain tumor (s), the frequency of epilepsy is 30% or more depending on type of tumeur.&#xD;
      30-50% of brain tumors are revealed by an epileptic seizure and 10 to 30% of patients with&#xD;
      brain tumor (s) will develop seizures during their evolution.&#xD;
&#xD;
      The main objective is to evaluate the frequency of epileptic seizures according to the type&#xD;
      of brain tumor.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The PI decided.&#xD;
  </why_stopped>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of epileptic seizures</measure>
    <time_frame>Day 1</time_frame>
    <description>number of epileptic seizures at the time of neurology consultation or hospitalization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of epileptic seizures</measure>
    <time_frame>until 10 years</time_frame>
    <description>number of epileptic seizures at every visit</description>
  </secondary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Epilepsy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized following an epileptic seizure or seen in consultation in the&#xD;
        neurology department of the GHPSJ, diagnosed with primary or secondary brain tumor from&#xD;
        January 2013 to December 2023.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient whose age â‰¥ 18 years&#xD;
&#xD;
          -  Patient hospitalized or seen in consultation in the Department of Neurology within the&#xD;
             Hospital Group Paris Saint-Joseph&#xD;
&#xD;
          -  Diagnosis of primary or secondary brain tumor, radiologically and / or histologically&#xD;
&#xD;
          -  Epilepsy revealing or occurring in a patient developing a brain tumor&#xD;
&#xD;
          -  Francophone patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre-existing and known epilepsy before the diagnosis of brain tumors&#xD;
&#xD;
          -  Epilepsy occurring within 2 weeks postoperatively&#xD;
&#xD;
          -  Anteriority of taking antiepileptic treatment&#xD;
&#xD;
          -  Patient under tutorship or curatorship&#xD;
&#xD;
          -  Patient deprived of liberty&#xD;
&#xD;
          -  Patient with comprehension disorders making it impossible to understand the protocol&#xD;
&#xD;
          -  Patient or relative opposing the use of his data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roubeau Vincent, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Paris Saint Joseph</affiliation>
  </overall_official>
  <removed_countries>
    <country>France</country>
  </removed_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 7, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

